Rebecca Comeau

Ketamine for mental health - A naturalistic inventory of prescribing practices, safety, and adverse effects

PLOS mental health April 2, 2025 Marta Stuart, Ian Stefanuk, Rebecca Comeau et al. 1 citation

Ketamine is an NMDA receptor antagonist, long used for its anesthetic and pain reducing properties, but has more recently demonstrated efficacy for treating depression. Evidence is also emerging for other psychiatric indications including posttraumatic stress disorder, anxiety disorders, obsessive compulsive disorder, and to support psychotherapy. In this context, there is greater demand for...